DV Biomed Co., Ltd. (6539) Stock Statistics & Valuation Metrics
Total Valuation
DV Biomed Co., Ltd. has a market cap or net worth of TWD 845.25M. The enterprise value is ―.
- Market Cap
- TWD 845.25M
- Enterprise Value
- ―
Share Statistics
DV Biomed Co., Ltd. has 24,349,415 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 24,349,415
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
DV Biomed Co., Ltd.’s return on equity (ROE) is 0.02 and return on invested capital (ROIC) is 2.14%.
- Return on Equity (ROE)
- 0.02
- Return on Assets (ROA)
- 0.01
- Return on Invested Capital (ROIC)
- 2.14%
- Return on Capital Employed (ROCE)
- 0.03
- Revenue Per Employee
- 2.44M
- Profits Per Employee
- 23.73K
- Employee Count
- 326
- Asset Turnover
- 1.17
- Inventory Turnover
- 2.28
Valuation Ratios
The current PE Ratio of DV Biomed Co., Ltd. is 11.46. DV Biomed Co., Ltd.’s PEG ratio is 0.25.
- PE Ratio
- 11.46
- PS Ratio
- 1.11
- PB Ratio
- 1.60
- Price to FCF
- 17.49
- Price to Operating Cash Flow
- 12.55
- PEG Ratio
- 0.25
Income Statement
In the last 12 months, DV Biomed Co., Ltd. had revenue of 794.18M and earned 7.74M in profits. Earnings per share was 0.32.
- Revenue
- 794.18M
- Gross Profit
- 566.63M
- Operating Income
- 14.86M
- Pretax Income
- 10.11M
- Net Income
- 7.74M
- EBITDA
- 50.27M
- Earnings Per Share (EPS)
- 0.32
Cash Flow
In the last 12 months, operating cash flow was 70.23M and capital expenditures -19.84M, giving a free cash flow of 50.39M billion.
- Operating Cash Flow
- 70.23M
- Free Cash Flow
- 50.39M
- Free Cash Flow per Share
- 2.07
Dividends & Yields
DV Biomed Co., Ltd. pays an annual dividend of ―, resulting in a dividend yield of 4.42%
- Dividend Per Share
- ―
- Dividend Yield
- 4.42%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 5.72%
- Earnings Yield
- 8.69%
Stock Price Statistics
- Beta
- 0.16
- 52-Week Price Change
- -35.36%
- 50-Day Moving Average
- ―
- 200-Day Moving Average
- ―
- Relative Strength Index (RSI)
- 44.08
- Average Volume (3m)
- 2,160
Financial Position
DV Biomed Co., Ltd. as a current ratio of 3.55, with Debt / Equity ratio of 8.97%
- Current Ratio
- 3.55
- Quick Ratio
- 2.83
- Debt to Market Cap
- 0.01
- Net Debt to EBITDA
- -1.36
- Interest Coverage Ratio
- 9.90
Taxes
In the past 12 months, DV Biomed Co., Ltd. has paid 2.02M in taxes.
- Income Tax
- 2.02M
- Effective Tax Rate
- 0.20
Enterprise Valuation
DV Biomed Co., Ltd. EV to EBITDA ratio is 7.67, with an EV/FCF ratio of 16.23.
- EV to Sales
- 1.03
- EV to EBITDA
- 7.67
- EV to Free Cash Flow
- 16.23
- EV to Operating Cash Flow
- 11.65
Balance Sheet
DV Biomed Co., Ltd. has TWD 358.56M in cash and marketable securities with TWD 36.65M in debt, giving a net cash position of TWD 321.91M billion.
- Cash & Marketable Securities
- TWD 358.56M
- Total Debt
- TWD 36.65M
- Net Cash
- TWD 321.91M
- Net Cash Per Share
- TWD 13.22
- Tangible Book Value Per Share
- TWD 22.49
Margins
Gross margin is 72.53%, with operating margin of 9.33%, and net profit margin of 9.63%.
- Gross Margin
- 72.53%
- Operating Margin
- 9.33%
- Pretax Margin
- 11.78%
- Net Profit Margin
- 9.63%
- EBITDA Margin
- 13.40%
- EBIT Margin
- 9.33%
Analyst Forecast
The average price target for DV Biomed Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 11.59%
- EPS Growth Forecast
- 54.39%
